Differential perpetuation of malaria species among Amazonian Yanomami Amerindians

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 5, 1999, Pages 767-773

  Laserson, Kayla F ^a   Wypij, David ^b   Petralanda, Izaskun ^c   Spielman, Andrew ^b   Maguire, James H ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Asoc Civ Invest Contr E   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AMERICAN INDIAN; ANOPHELES; ARTICLE; CHILD; ENDEMIC DISEASE; EPIDEMIC; FEMALE; HUMAN; INFECTION RATE; MALARIA; MALE; MULTIVARIATE ANALYSIS; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 0032922908     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.767     Document Type: Article

References (39)

1. de Albuquerque BC, 1992. Reorganization of the Brazilian Amazon region and malaria control. Mem Inst Oswaldo Cruz 87 (suppl III): 341.
2. Veeken H, 1993. Malaria and gold fever. Br Med J 307: 433-434.
3. Sawyer DR, 1992. Malaria and the Environment. Brasilia: Instituto Sociedade Populacaó e Natureza. Documento de Trabalho 13: 1-37.
4. Fuentes M, Felicita S, Lopez A, Garcia M, Hung S, Petralanda I, 1992. Estudios epidemiologicos sobre malaria en el Amazonas: 1990-1992. Mem CAICET 2: 13-15.
5. Laserson K, Gonzalez M, Alvarez R, Petralanda I, 1994. Estudios sobre malaria: comunicacion preliminar. Mem CAICET 4: 58-61.
6. Matos A, Petralanda I, 1994. Caracteristicas Clinicas, Patologicas y Serologicas de Casos de Malaria Procedentes de la Sierra de Parima, Amazonas, Venezuela. Puerto Ayacucho, Venezuela: CAICET Pub. Cient. No. 65.
7. Colchester M, 1985. The Health and Survival of the Venezuelan Yanomami. IWGIA Document 53, Copenhagen: ARC, IWGIA and Survival International.
8. Torres J, Nava O, Mondolfi A, Peceno C, Botto C, 1988. Hyperreactive malaria splenomegaly in Venezuela. Am J Trop Med Hyg 39: 11-14.
9. CAICET, 1988. Informe Anual de Actividades. Puerto Ayacucho, Venezuela: CAICET, 16-28.
10. CAICET, 1990. Informe Anual de Actividades. Puerto Ayacucho, Venezuela: CAICET, 24-26, 46.
11. Lopez U, Thompson G, Hung S, Lopez A, Fuentes M, Garrido E, Petralanda I, 1992. Analisis de las principales causas de morbi-mortalidad en la poblacion Yanomami de Sierra Parima, Venezuela: 1990-1992. CAICET 2: 25-28.
12. Ministerio de Sanidad y Assistencia Social, 1993. Memoria y Cuenta 1992. Republica de Venezuela, Caracas, 205-240.
13. Oficina Central de Estadistica e Informatica (OCEI), 1985. Censo Indigena de Venezuela: Nomenclador de las Comunidades y Colectividades. Republica de Venezuela: Oficina de Estatistica e Informatica.
14. Good K, 1995. The Yanomami keep on trekking. Nat History 104: 56-65.
15. Smole WJ, 1976. The Yanoama Indians: A Cultural Geography. Austin, TX: University of Texas Press.
16. Rombo L, Bjorkman A, Sego E, Lindstrom B, Ericsson O, Gustafsson LL, 1985. Reliability of the Dill-Glazko test. Lancet 1: 1509.
17. Verdier F, Ramanamirija JA, Pussard E, Clavier F, Biaud JM, Coulanges P, LeBras J, 1985. Unreliability of the Dill-Glazko test in detecting chloroquine in urine. Lancet 1: 1282-1283.
18. Cova-Garcia, P, 1961. Notas sobre los anofelinos de Venezuela y su identification. Publicaciones de la Division de Malaria, Ministerio de Sanidad y Asistencia Social. Caracas, Venezuela: Editora Grafos, C.A.
19. Kemp WHW, 1942. The anopheline mosquitoes of the Carribean region. NIH Bulletin 179. Washington, DC: The United States Government Printing Office.
20. Russel PF, Rozeboom LE, Stone A, 1943. Keys to the Anopheline Mosquitoes of the World. Philadelphia: The American Entomological Society. The Academy of Natural Sciences.
21. Anderson RM, May RM, 1992. Infectious Disease of Humans: Dynamics and Control. Oxford: Oxford University Press.
22. Molineaux L, Gramiccia G, 1980. The Garki Project. Geneva: World Health Organization.
23. Wernsdorfer WH, McGregor I, eds, 1988. Malaria: Principles and Practices of Malariology. Volume 2. New York: Churchill and Livingstone.
24. StataCorp, 1997. Stata Statistical Software. Release 5.0. College Station, TX: Stata Corporation.
25. Zeger S, Liang K, 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130.
26. Petralanda I, 1995. Quality of antimalarial drugs and resistance to Plasmodium vivax in the Amazonian region. Lancet 345: 1433.
27. Gupta S, Swinton J, Anderson R, 1994. Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proc R Soc Lond Ser B Biol Sci 256: 231-238.
28. Gupta S, Hill AV, Kwiatkowski D, Greenwood AM, Greenwood BM, Day KP, 1994. Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci 91: 3715-3719.
29. Gupta S, Trenholme K, Anderson RM, Day KP, 1994. Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science 263: 961-963.
30. Gupta S, Day K, 1994. A theoretical framework for the immunoepidemiology of Plasmodium falciparum. Parasitol Immunol 16: 361-370.
31. Gupta S, Day K, 1994. A strain theory of transmission. Parasitol Today 10: 476-481.
32. Day K, Marsh K, 1991. Naturally acquired immunity to Plasmodium falciparum. Parasitol Today 7: A68-A71.
33. Allan RJ, Beattie P, Bate C, Van Hensbroek MB, Morris-Jones S, Greenwood B, Kwiatkowski D, 1995. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect Immun 63: 1173-1175.
34. Sawyer DR, 1993. Economic and social consequences of malaria in new colonialization projects in Brazil. Soc Sci Med 37: 1131-1136.
35. Al-Yaman F, Genton B, Falk M, Anders RF, Lewis D, Hii J, Beck H, Alpers MP, 1995. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 52: 66-71.
36. Bernabe FF, Chumpitazi FF, Deloron P, Peyron F, Boudin C, Picot S, Ambroise-Thomas P, 1991. Relationships between clinical protection and antibodies to Plasmodium falciparum RESA (ring infected erythrocyte surface antigen) peptides. Int J Parasitol 21: 271-274.
37. Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow D, Holder AA, Riley EM, 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, pfMSP-1. J Infect Dis 173: 765-769.
38. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM, 1989. Antibodies to blood stage antigens of Plasmodium falciparum and their relation to protection against infection. Trans R Soc Trop Med Hyg 83: 293-303.
39. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennet S, Takacs B, Schonfeld HJ, Holder AA, Greenwood BM, 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasitol Immunol 14: 321-337.